• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome.

作者信息

Gomez M T, Magiakou M A, Mastorakos G, Chrousos G P

机构信息

Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

J Clin Endocrinol Metab. 1993 Jul;77(1):173-7. doi: 10.1210/jcem.77.1.8392083.

DOI:10.1210/jcem.77.1.8392083
PMID:8392083
Abstract

Patients cured from endogenous Cushing syndrome usually develop postoperative adrenal suppression in the year ensuing surgery. To define whether the pituitary corticotroph is the rate limiting step in the postoperative recovery of this secondary/tertiary form of adrenal insufficiency, we examined surgically cured patients with Cushing syndrome 10 days, 3 months, and 6-12 months after surgery, by administering ovine CRH (oCRH) iv at the dose of 1 microgram/kg.h over 24 h. The pituitary corticotroph of these patients responded vigorously to oCRH, with ACTH concentrations reaching above the normal range at all three times of testing. Parallel measurements of cortisol in nonadrenalectomized patients demonstrated subnormal adrenal responsiveness at 10 days and 3 months and normalization at 6-12 months after surgery. The circadian rhythm of ACTH was maintained postoperatively at 10 days and 6-12 months, and the circadian rhythm of cortisol was also present at 6-12 months after surgery, in spite of the constant infusions of pharmacological doses of oCRH, suggesting that factors other than CRH secretion regulate this rhythm. We conclude that the corticotroph is not the rate limiting step in the recovery of the hypothalamic-pituitary-adrenal axis from glucocorticoid-induced adrenal suppression, and that the locus of the defect resides in the hypothalamic CRH neuron and/or its higher regulatory inputs.

摘要

相似文献

1
The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome.
J Clin Endocrinol Metab. 1993 Jul;77(1):173-7. doi: 10.1210/jcem.77.1.8392083.
2
The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.脉冲式给予人促肾上腺皮质激素释放激素对库欣病治愈后肾上腺功能不全的影响。
J Clin Endocrinol Metab. 1989 May;68(5):912-6. doi: 10.1210/jcem-68-5-912.
3
The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.促肾上腺皮质激素释放激素试验在库欣综合征患者术后评估中的应用
J Clin Endocrinol Metab. 1987 Nov;65(5):906-13. doi: 10.1210/jcem-65-5-906.
4
The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.危重病中的下丘脑-垂体-肾上腺轴:对地塞米松和促肾上腺皮质激素释放激素的反应
J Clin Endocrinol Metab. 1993 Jul;77(1):151-6. doi: 10.1210/jcem.77.1.8392081.
5
Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.大剂量糖皮质激素治疗6周前后白血病患儿下丘脑-垂体-肾上腺轴的评估
J Clin Endocrinol Metab. 2001 Jul;86(7):2993-6. doi: 10.1210/jcem.86.7.7629.
6
Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.促肾上腺皮质激素释放激素:与正常生理学、高皮质醇血症及肾上腺功能不全的病理生理学和鉴别诊断的相关性
Adv Biochem Psychopharmacol. 1987;43:183-200.
7
Pituitary-adrenal responsiveness to corticotropin-releasing hormone in patients receiving chronic, alternate day glucocorticoid therapy.接受隔日长期糖皮质激素治疗的患者垂体-肾上腺对促肾上腺皮质激素释放激素的反应性。
J Clin Endocrinol Metab. 1985 Jul;61(1):22-7. doi: 10.1210/jcem-61-1-22.
8
Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.重复给予促肾上腺皮质激素释放激素联合赖氨酸加压素对继发性肾上腺皮质功能不全患者血浆促肾上腺皮质激素和皮质醇水平的影响
J Clin Endocrinol Metab. 1990 Dec;71(6):1624-31. doi: 10.1210/jcem-71-6-1624.
9
Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.库欣综合征的诊断与管理:一项意大利多中心研究的结果。意大利内分泌学会下丘脑 - 垂体 - 肾上腺轴病理生理学研究组
J Clin Endocrinol Metab. 1999 Feb;84(2):440-8. doi: 10.1210/jcem.84.2.5465.
10
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.慢性疲劳综合征患者下丘脑-垂体-肾上腺轴激活受损的证据。
J Clin Endocrinol Metab. 1991 Dec;73(6):1224-34. doi: 10.1210/jcem-73-6-1224.

引用本文的文献

1
Rapid hypothalamic-pituitary recovery after chronic glucocorticoid therapy enables strategies that prevent adrenal suppression.长期糖皮质激素治疗后下丘脑 - 垂体的快速恢复使得预防肾上腺抑制的策略成为可能。
bioRxiv. 2025 May 4:2025.04.30.651350. doi: 10.1101/2025.04.30.651350.
2
Impact of hydrocortisone vs prednisone therapy on postsurgical recovery in patients with endogenous hypercortisolism: a prospective cohort study.氢化可的松与泼尼松治疗对库欣综合征患者术后恢复的影响:一项前瞻性队列研究
Eur J Endocrinol. 2025 Apr 30;192(5):621-630. doi: 10.1093/ejendo/lvaf092.
3
Exploratory Study of the Association of Genetic Factors With Recovery of Adrenal Function in Cushing Disease.
库欣病中遗传因素与肾上腺功能恢复相关性的探索性研究
J Endocr Soc. 2023 Apr 25;7(6):bvad046. doi: 10.1210/jendso/bvad046. eCollection 2023 May 5.
4
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.内源性库欣综合征治疗后发生的糖皮质激素撤药综合征。
Pituitary. 2022 Jun;25(3):393-403. doi: 10.1007/s11102-022-01218-y. Epub 2022 Apr 26.
5
Variation in glucocorticoid sensitivity and the relation with obesity.糖皮质激素敏感性的变化与肥胖的关系。
Obes Rev. 2022 Mar;23(3):e13401. doi: 10.1111/obr.13401. Epub 2021 Nov 27.
6
Recovery of hypothalamic-pituitary-adrenal axis in paediatric Cushing disease.儿童库欣病下丘脑-垂体-肾上腺轴的恢复。
Clin Endocrinol (Oxf). 2021 Jan;94(1):40-47. doi: 10.1111/cen.14300. Epub 2020 Sep 14.
7
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.针对肾上腺功能不全的糖皮质激素替代治疗的调整:意大利内分泌学会专家意见。
J Endocrinol Invest. 2020 May;43(5):683-696. doi: 10.1007/s40618-019-01146-y. Epub 2019 Nov 26.
8
Adrenal function and dysfunction in critically ill patients.危重症患者的肾上腺功能和功能障碍。
Nat Rev Endocrinol. 2019 Jul;15(7):417-427. doi: 10.1038/s41574-019-0185-7.
9
ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.急性、亚急性和慢性危重病患者 CRH 刺激下的 ACTH 和皮质醇反应:一项随机、双盲、安慰剂对照、交叉队列研究。
Intensive Care Med. 2018 Dec;44(12):2048-2058. doi: 10.1007/s00134-018-5427-y. Epub 2018 Oct 29.
10
Delayed Presentation of Isolated Adrenocorticotropin Insufficiency after Nivolumab Therapy for Advanced Non-small-cell lung carcinoma (NSCLC).纳武单抗治疗晚期非小细胞肺癌(NSCLC)后孤立性促肾上腺皮质激素缺乏的延迟表现
BMJ Case Rep. 2018 Aug 8;2018:bcr-2018-225048. doi: 10.1136/bcr-2018-225048.